دورية أكاديمية

Hydralazine Revives Cellular and Ocular Lens Health-Span by Ameliorating the Aging and Oxidative-Dependent Loss of the Nrf2-Activated Cellular Stress Response

التفاصيل البيبلوغرافية
العنوان: Hydralazine Revives Cellular and Ocular Lens Health-Span by Ameliorating the Aging and Oxidative-Dependent Loss of the Nrf2-Activated Cellular Stress Response
المؤلفون: Bhavana Chhunchha, Eri Kubo, Ronald R. Krueger, Dhirendra P. Singh
المصدر: Antioxidants, Vol 12, Iss 1, p 140 (2023)
بيانات النشر: MDPI AG, 2023.
سنة النشر: 2023
المجموعة: LCC:Therapeutics. Pharmacology
مصطلحات موضوعية: aging, oxidative stress, antioxidants, Nrf2, peroxiredoxin 6, hydralazine, Therapeutics. Pharmacology, RM1-950
الوصف: A major hallmark of aging-associated diseases is the inability to evoke cellular defense responses. Transcriptional protein Nrf2 (nuclear factor erythroid-derived 2-related factor) plays a pivotal role in the oxidative stress response, cellular homeostasis, and health span. Nrf2’s activation has been identified as a therapeutic target to restore antioxidant defense in aging. Here, we demonstrated that FDA-approved drug, hydralazine (Hyd), was a reactivator of the Nrf2/ARE (antioxidant response element) pathway in various ages and types of mouse (m) or human (h) lens epithelial cells (LECs) and mice lenses in-vitro/in-vivo. This led to Hyd-driven abatement of carbonyls, reduced reactive oxygen species (ROS), and reduced 4-HNE/MDA-adducts with cytoprotection, and extended lens healthspan by delaying/preventing lens opacity against aging/oxidative stress. We elucidated that Hyd activated the protective signaling by inducing Nrf2 to traverse from the cytoplasm to the nucleus and potentiated the ARE response by direct interaction of Nrf2 and ARE sequences of the promoter. Loss-of-function study and cotreatment of Hyd and antioxidant, N-acetyl cysteine (NAC) or Peroxiredoxin (Prdx)6, specified that Nrf2/ARE-driven increase in the promoter activity was Hyd-dependent. Our study provides proof-of concept evidence and, thereby, paves the way to repurposing Hyd as a therapeutic agent to delay/prevent aging and oxidative-related disorders.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2076-3921
54115183
Relation: https://www.mdpi.com/2076-3921/12/1/140; https://doaj.org/toc/2076-3921
DOI: 10.3390/antiox12010140
URL الوصول: https://doaj.org/article/ad798a0d5d9a4605bb54115183f3fabf
رقم الأكسشن: edsdoj.798a0d5d9a4605bb54115183f3fabf
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:20763921
54115183
DOI:10.3390/antiox12010140